Alteogen Inc. Logo

Alteogen Inc.

Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):
KR7196170005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시

Description

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2026-01-08 00:00
기업설명회(IR)개최
Korean 7.2 KB
2025-12-26 00:00
대표이사변경
Korean 9.8 KB
2025-09-10 00:00
기업설명회(IR)개최
Korean 6.7 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 2.1 MB
2025-05-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-13 00:00
분기보고서 (2025.03)
Korean 2.1 MB
2025-04-30 00:00
소속부변경
Korean 3.6 KB
2025-04-03 00:00
회사합병결정(종속회사의주요경영사항)
Korean 19.8 KB
2025-04-03 00:00
타법인주식및출자증권취득결정
Korean 16.6 KB
2025-04-03 00:00
주식등의대량보유상황보고서(일반)
Korean 117.7 KB
2025-03-31 00:00
정기주주총회결과
Korean 25.6 KB
2025-03-31 00:00
주식매수선택권부여에관한신고
Korean 15.1 KB
2025-03-26 00:00
기업설명회(IR)개최
Korean 6.7 KB
2025-03-21 00:00
감사보고서제출
Korean 25.1 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean 583.5 KB

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alteogen Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.